Intracerebral hemorrhage or ICH, most commonly known as cerebral bleed, occurs within the brain tissue and is a kind of intracranial bleed within the ventricles or brain tissue. Common symptoms include high blood pressure, low cholesterol, vomiting, weakness, one-sided headache, neck stiffness, and decreased level of consciousness. The main causes of brain hemorrhage are arteriovenous malformations, brain trauma, brain tumor, and aneurysms.
Brain Bleeding Could Be Stopped With the Drug
Scientists in London have recently discovered a drug for the treatment of urea-related disorders, which may ultimately lessen bleeding in the brain and risk of having a stroke as well. According to scientists strokes are caused by a gene known as collagen IV. The mutations of Collagen IV affects the blood vessels in the brain. The end result of this may be bleeding in the interiors of the brain. This situation may occur to anyone irrespective of their age and gender, and even during childhood.
Scientists from the University of Edinburgh and the University of Manchester, examined mice, having similar defect in their collagen IV. They found that this gene defect later developed into the same disease as in human patients. They concluded from the work that the use of sodium phenyl butyric acid could reduce the bleeding of the brain. The details and the findings of the study were published in the Human Molecular Genetics journal. Even though there was a ray of hope found in the brain bleeding field, the treatment discovered still could not treat kidney or eye diseases related with these genetic defects. Further research is in progress in order to find better clinical solutions for treating brain hemorrhage.